4.7 Article

Sequential ubiquitination of NLRP3 by RNF125 and Cbl-b limits inflammasome activation and endotoxemia

期刊

JOURNAL OF EXPERIMENTAL MEDICINE
卷 217, 期 4, 页码 -

出版社

ROCKEFELLER UNIV PRESS
DOI: 10.1084/jem.20182091

关键词

-

资金

  1. Carver Foundation
  2. Howard Hughes Medical Institute
  3. US National Institutes of Health [R01 AI090901, R01 AI121196, R01 AI123253, R21 AI117547]
  4. American Heart Association [16GRNT26990004]
  5. NATIONAL CANCER INSTITUTE [ZIABC010977] Funding Source: NIH RePORTER

向作者/读者索取更多资源

Aberrant NLRP3 inflammasome activation contributes to the development of endotoxemia. The importance of negative regulation of NLRP3 inflammasomes remains poorly understood. Here, we show that the E3 ubiquitin ligase Cbl-b is essential for preventing endotoxemia induced by a sub-lethal dose of LPS via a caspase-11/NLRP3-dependent manner. Further studies show that NLRP3 undergoes both K63- and K48-linked polyubiquitination. Cbl-b binds to the K63-ubiquitin chains attached to the NLRP3 leucine-rich repeat domain (LRR) via its ubiquitin-associated region (UBA) and then targets NLRP3 at K496 for K48-linked ubiquitination and proteasome-mediated degradation. We also identify RNF125 as an additional E3 ubiquitin ligase that initiates K63-linked ubiquitination of the NLRP3 LRR domain. Therefore, NLRP3 is sequentially ubiquitinated by K63- and K48-linked ubiquitination, thus keeping the NLRP3 inflammasomes in check and restraining endotoxemia.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据